Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5282683
Max Phase: Preclinical
Molecular Formula: C37H44O9
Molecular Weight: 632.75
Associated Items:
ID: ALA5282683
Max Phase: Preclinical
Molecular Formula: C37H44O9
Molecular Weight: 632.75
Associated Items:
Canonical SMILES: C=C(C)/C=C/C1(C)C=CC2=C(O1)C(CC=C(C)C)=C1O[C@]34C(C(=O)[C@@H]1C2O)[C@@H](O)[C@@H]1C[C@H]3C(C)(C)O[C@@]4(C/C=C(\C)C(=O)O)C1=O
Standard InChI: InChI=1S/C37H44O9/c1-18(2)9-10-22-30-21(13-15-35(8,44-30)14-11-19(3)4)27(38)25-29(40)26-28(39)23-17-24-34(6,7)46-36(32(23)41,16-12-20(5)33(42)43)37(24,26)45-31(22)25/h9,11-15,23-28,38-39H,3,10,16-17H2,1-2,4-8H3,(H,42,43)/b14-11+,20-12+/t23-,24-,25-,26?,27?,28-,35?,36-,37-/m0/s1
Standard InChI Key: UXCYFRLWCQPQBC-CYDVFSFBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 632.75 | Molecular Weight (Monoisotopic): 632.2985 | AlogP: 4.82 | #Rotatable Bonds: 7 |
Polar Surface Area: 139.59 | Molecular Species: ACID | HBA: 8 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 3.91 | CX Basic pKa: | CX LogP: 3.39 | CX LogD: 0.18 |
Aromatic Rings: 0 | Heavy Atoms: 46 | QED Weighted: 0.20 | Np Likeness Score: 2.77 |
1. Santos CMM, Freitas M, Fernandes E.. (2018) A comprehensive review on xanthone derivatives as α-glucosidase inhibitors., 157 [PMID:30282319] [10.1016/j.ejmech.2018.07.073] |
Source(1):